Ardy Arianpour is now senior vice president of business development at Ambry Genetics. He previously served as vice president of business development at the company. Arianpour joined Ambry in 2009 after holding several positions at Cogenics.
Nanosphere's former president and CEO William Moffitt has taken on the post of executive chairman at GlySure, a UK-based company that has developed a glucose monitoring system.
Moffitt left Nanosphere in February. Before he ended his tenure at the Northbrook, Ill.-based molecular diagnostics firm, he was president and CEO of i-STAT, and prior to that, he held executive posts at Baxter Healthcare and American Hospital Supply.
Combimatrix's shareholders have re-elected their board of directors to continue serving until the 2014 shareholder meeting. The re-elected board includes President and CEO Mark McDonough, former CEO and executive chairman Judd Jessup, Chief Medical Officer Richard Hockett, Scott Gottlieb, Wei Richard Ding, and Jeremy Jones.